CHIMERIC CD4/IMMUNOGLOBULIN ANTIBODIES FOR AIDS
TANOX, INC. · Department of Health and Human Services
Phase I1989$44,192
ONE OF THE MOST URGENT CHALLENGES FACING THE MEDICAL COMMUNITY IS THE DEVELOPMENT OF EFFECTIVE THERAPEUTIC AGENTSFOR VICTIMS OF THE WORLDWIDE AIDS EPIDEMIC. BECAUSE OF THEIR HIGH DEGREE OF SPECIFICITY AND HIGHLY SPECIAL…